NEW YORK (

TheStreet

) --

STOCK COMMENTS / EPS CHANGES

Baxter International

(BAX) - Get Report

is upgraded to buy at TheStreet Ratings.

Brinker

(EAT) - Get Report

numbers raised at UBS. Shares of EAT now seen reaching $30. Estimates also increased on positive SSS. Buy rating.

Expedia

(EXPE) - Get Report

numbers raised at UBS. Shares of EXPE now seen reaching $33. Estimates also increased after TipAdvisor spin off. Neutral rating.

Mead Johnson Nutrition

(MJN)

numbers lowered at Goldman Sachs. Shares of MJN now seen reaching $74. Estimates also lowered on product safety fears. Neutral rating.

Everest Re

(RE) - Get Report

numbers lowered at UBS. Shares of RE now seen reaching $105. Estimates also lowered on Thailand floods. Buy rating.

Salix Pharmaceuticals

numbers raised at Goldman Sachs. Shares of SLXP now seen reaching $46. Estimates also raised on positive Phase III data. Neutral rating.

United Continental

(UAL) - Get Report

estimates lowered at UBS through 2012. Company guides down. Buy rating and $35 price target.

Walgreen

(WAG)

numbers lowered at Jefferies. Shares of WAG now seen reaching $34. Estimates also lowered on ongoing uncertainty surrounding the ESRX contract. Hold rating.

>To submit a news tip, email:

tips@thestreet.com

.

RELATED STORIES:

>>The 10 Dumbest Things on Wall Street in 2011

>>Energy IPOs Poised to Heat Up in 2012

Follow

TheStreet

on

Twitter

and become a fan on

Facebook.

This article was written by a staff member of RealMoney.com.